Company: HURA
Filing Date: 2025-09-18
Form Type: S-1/A
Source: 0001193125-25-207395
Chunk: 239

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-09-18
Form: S-1/A
Chunk 239
---
ated Statements of Stockholders’ Equity (Deficit) for the Six Months Ended June 30, 2025 and 2024 |     | F-96 |
| Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2025 and 2024                     |     | F-97 |
| Notes to the Consolidated Financial Statements                                                            |     | F-98 |

F-1

KINETA FINANCIAL STATEMENTS

| Report of Independent Registered Public Accounting Firm                                                                  
 Consolidated Balance Sheets as of December 31, 2024 and 2023                                                             
 Consolidated Statements of Operations for the Years Ended December 31, 2024 and 2023                                     |     | F-111 
 F-113 
 F-114 |
|:-------------------------------------------------------------------------------------------------------------------------|:----|:------|
| Consolidated Statements of Stockholders’ Equity (Deficit) for the Years Ended December 31, 2024 and 2023                 |     | F-115 |
| Consolidated Statements of Cash Flows for the Years Ended December 31, 2024 and 2023                                     |     | F-116 |
| Notes to the Consolidated Financial Statements                                                                           |     | F-117 |
| Consolidated Balance Sheets as of March 31, 2025 (unaudited) and December 31, 2024                                       |     | F-150 |
| Consolidated Statements of Operations for the Three Months Ended March 31, 2025 and 2024 (unaudited)                     |     | F-151 |
| Consolidated Statements of Stockholders’ Equity (Deficit) for the Three Months Ended March 31, 2025 and 2024 (unaudited) |     | F-152 |
| Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2025 and 2024 (unaudited)                     |     | F-153 |
| Notes to the Unaudited Consolidated Financial Statements                                                                 |     | F-154 |

UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION

| Unaudited Pro Forma Condensed Combined Statements of Operations for the Period Ended June 29, 2025   
 Unaudited Pro Forma Condensed Combined Statements of Operations for the Year ended December 31, 2024 |     | F-181 
 F-182 |
|:-----------------------------------------------------------------------------------------------------|:----|:------|
| Notes